老年皮肤瘙痒症诊断与治疗专家共识

2018-11-30 中国中西医结合学会皮肤性病专业委员会 中国皮肤性病学杂志.2018.32(11):1233-1237.

皮肤瘙痒症在皮肤科临床常见,女性多于男性,亚洲人多于白种人,秋冬季节发病更为常见[1]。其发病率随年龄增加而逐渐升高,国外流行病学研究显示,65 岁门诊患者发病率为12%,85 岁以上患者发病率为20%。作为老年人最常见的皮肤疾患,我国尚缺乏相关流行病学数据,对老年皮肤瘙痒症的诊断和治疗仍不规范。为此,中国中西医结合学会皮肤性病专业委员会老年皮肤病学组制定了《老年皮肤瘙痒症诊断与治疗专家共识》,为

中文标题:

老年皮肤瘙痒症诊断与治疗专家共识

发布日期:

2018-11-30

简要介绍:

皮肤瘙痒症在皮肤科临床常见,女性多于男性,亚洲人多于白种人,秋冬季节发病更为常见[1]。其发病率随年龄增加而逐渐升高,国外流行病学研究显示,65 岁门诊患者发病率为12%,85 岁以上患者发病率为20%。作为老年人最常见的皮肤疾患,我国尚缺乏相关流行病学数据,对老年皮肤瘙痒症的诊断和治疗仍不规范。为此,中国中西医结合学会皮肤性病专业委员会老年皮肤病学组制定了《老年皮肤瘙痒症诊断与治疗专家共识》,为解决临床实际问题提供建议,以缓解或消除患者症状,提高患者生活质量。 

拓展指南:皮肤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=老年皮肤瘙痒症诊断与治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=a55601c0016e3af2, title=老年皮肤瘙痒症诊断与治疗专家共识, enTitle=, guiderFrom=中国皮肤性病学杂志.2018.32(11):1233-1237., authorId=null, author=, summary=皮肤瘙痒症在皮肤科临床常见,女性多于男性,亚洲人多于白种人,秋冬季节发病更为常见[1]。其发病率随年龄增加而逐渐升高,国外流行病学研究显示,65 岁门诊患者发病率为12%,85 岁以上患者发病率为20%。作为老年人最常见的皮肤疾患,我国尚缺乏相关流行病学数据,对老年皮肤瘙痒症的诊断和治疗仍不规范。为此,中国中西医结合学会皮肤性病专业委员会老年皮肤病学组制定了《老年皮肤瘙痒症诊断与治疗专家共识》,为, cover=, journalId=null, articlesId=null, associationId=175, associationName=中国中西医结合学会皮肤性病专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Nov 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>皮肤瘙痒症在皮肤科临床常见,女性多于男性,亚洲人多于白种人,秋冬季节发病更为常见[1]。其发病率随年龄增加而逐渐升高,国外流行病学研究显示,65 岁门诊患者发病率为12%,85 岁以上患者发病率为20%。作为老年人最常见的皮肤疾患,我国尚缺乏相关流行病学数据,对老年皮肤瘙痒症的诊断和治疗仍不规范。为此,中国中西医结合学会皮肤性病专业委员会老年皮肤病学组制定了《老年皮肤瘙痒症诊断与治疗专家共识》,为解决临床实际问题提供建议,以缓解或消除患者症状,提高患者生活质量。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>皮肤</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=f6f581c00166e77c" title="NCCN临床实践指南:原发性皮肤淋巴瘤(2019.V1)" target=_blank>NCCN临床实践指南:原发性皮肤淋巴瘤(2019.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6830f1c00166230f" title="2018 AAD指南:原发性皮肤黑色素瘤的管理" target=_blank>2018 AAD指南:原发性皮肤黑色素瘤的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5fc201c001661061" title="NCCN临床实践指南:皮肤黑色素瘤(2019.V1)" target=_blank>NCCN临床实践指南:皮肤黑色素瘤(2019.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8f1be1c001660096" title="NCCN临床实践指南:皮肤鳞状细胞癌(2019.V2)" target=_blank>NCCN临床实践指南:皮肤鳞状细胞癌(2019.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8edda1c0016a98f5" title="浙江省头孢菌素类抗生素皮肤过敏试验指导意见" target=_blank>浙江省头孢菌素类抗生素皮肤过敏试验指导意见</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%9A%AE%E8%82%A4" target=_blank>有关皮肤更多指南</a></ul>, tagList=[TagDto(tagId=84085, tagName=老年皮肤瘙痒症)], categoryList=[CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8150, appHits=513, showAppHits=0, pcHits=5944, showPcHits=2782, likes=103, shares=32, comments=5, approvalStatus=1, publishedTime=Sun Dec 09 15:12:57 CST 2018, publishedTimeString=2018-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 09 15:12:57 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 06:03:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=老年皮肤瘙痒症诊断与治疗专家共识)])
老年皮肤瘙痒症诊断与治疗专家共识
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069795, encodeId=40c71069e9557, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d95709031, createdName=ms8000000764575102, createdTime=Sat Nov 13 07:54:22 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906283, encodeId=f12d90628303, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d5267470, createdName=1481627fm11暂无昵称, createdTime=Wed Dec 09 09:09:34 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808599, encodeId=4828808599fb, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:20:12 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2021-11-13 ms8000000764575102

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069795, encodeId=40c71069e9557, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d95709031, createdName=ms8000000764575102, createdTime=Sat Nov 13 07:54:22 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906283, encodeId=f12d90628303, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d5267470, createdName=1481627fm11暂无昵称, createdTime=Wed Dec 09 09:09:34 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808599, encodeId=4828808599fb, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:20:12 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-12-09 1481627fm11暂无昵称

    学习了,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069795, encodeId=40c71069e9557, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36d95709031, createdName=ms8000000764575102, createdTime=Sat Nov 13 07:54:22 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906283, encodeId=f12d90628303, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d5267470, createdName=1481627fm11暂无昵称, createdTime=Wed Dec 09 09:09:34 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808599, encodeId=4828808599fb, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b83d5410816, createdName=Faye Hu, createdTime=Thu Aug 13 22:20:12 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 Faye Hu

    学习了,谢谢分享

    0